SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharmaceutical Industries informs about board meeting

10 May 2018 Evaluate

Sun Pharmaceutical Industries has informed that a meeting of the Board of Directors of the Company will be held on Friday, May 25, 2018, to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2018, to consider recommendation of dividend for the year ended March 31, 2018 subject to the approval of the shareholders at the ensuing Annual General Meeting. In view of the consideration of above, the window closure for trading by designated persons as per Insider Trading Rules of the Company will be from Wednesday, May 16, 2018 to Tuesday, May 29, 2018.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1847.30 12.90 (0.70%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×